|
|
Volumn 98, Issue 14, 2012, Pages 1091-1097
|
|
Predicting the adverse risk of statin treatment: An independent and external validation of Qstatin risk scores in the UK
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ACUTE KIDNEY FAILURE;
ADULT;
ADVERSE OUTCOME;
AGED;
ARTICLE;
CALIBRATION;
CARDIOVASCULAR DISEASE;
CATARACT;
COHORT ANALYSIS;
DISCRIMINANT ANALYSIS;
DISEASE SEVERITY;
DRUG SAFETY;
FEMALE;
GENERAL PRACTICE;
HIGH RISK PATIENT;
HUMAN;
LIVER DYSFUNCTION;
MAJOR CLINICAL STUDY;
MALE;
MYOPATHY;
PREDICTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
QSTATIN SCORE;
RECEIVER OPERATING CHARACTERISTIC;
RISK ASSESSMENT;
SCORING SYSTEM;
SEX DIFFERENCE;
TREATMENT DURATION;
UNITED KINGDOM;
VALIDATION PROCESS;
ACUTE KIDNEY INJURY;
ADULT;
AGED;
AGED, 80 AND OVER;
CARDIOVASCULAR DISEASES;
CATARACT;
DRUG-INDUCED LIVER INJURY;
FEMALE;
GREAT BRITAIN;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INCIDENCE;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RISK ASSESSMENT;
|
|
EID: 84862888893
PISSN: 13556037
EISSN: 1468201X
Source Type: Journal
DOI: 10.1136/heartjnl-2012-302014 Document Type: Article |
|
Times cited : (29)
|
|
References (11)
|
